Cholesteryl ester transfer protein inhibitors are of interest to researchers because they not only have the potential to increase HDL-C levels but also have been associated with a reduction in the incidence of diabetes and an improvement in glucose metabolism55. Here, CETP is linked to diabetes mellitus.